Search results

Order by most recent / most popular / relevance

Results: 1-10 of 247

Interim relief granted in challenge to EMA's decision to disclose pre-clinical and clinical information from an application for a centralised marketing authorisation

Arnold & Porter LLP
-
European Union
-
May 7 2013

InterMune UK Ltd and its associated companies have challenged a decision of the European Medicines Agency (EMA) to disclose to a third party

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

IP challenges for the personalised medicines industry - gene claims (part 1)

Barker Brettell LLP
-
European Union, United Kingdom, USA
-
May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

Shook Hardy & Bacon LLP
-
European Union
-
May 16 2013

According to a news source, European Medicines Agency (EMA) Director Guido Rasi intends to appeal interim rulings recently issued by the European

EPO shies away from taking a stand on human embryonic stem cells

Dehns
-
European Union
-
April 19 2013

Inventions which necessarily involve the destruction of a human embryo are excluded from patentability in Europe. However, in recent years there have

First court ruling on the EU nutrition and health claims regulation “health claim” given a very broad meaning

Eversheds LLP
-
European Union
-
September 26 2012

The first judicial interpretation of the controversial EU Nutrition and Health Claims Regulation has just been released

Dutch Supreme Court raises prejudicial questions to European Court of Justice regarding relief from import duties for certain pharmaceutical substances

Greenberg Traurig LLP
-
European Union, Netherlands
-
January 22 2010

On December 18, 2009, the Dutch Supreme Court provided an important judgment for companies in the pharmaceutical industry

Overview of patent-statutory subject matter in biotechnology

CCPIT Patent & Trademark Law Office
-
China, European Union, Japan, USA
-
April 8 2013

With the advent of biotechnology, the human community stands on the threshold of an extraordinary revolution having profound

Ban on embryonic stem cell patenting in Europe Court of Justice rules on meaning of "human embryo" in stem cells debate

Hogan Lovells
-
European Union, Germany
-
October 25 2011

The Court of Justice of the European Union (CJEU) handed down its long-awaited judgment in the Brüstle case on the patentability of stem cell inventions

German Supreme Court finally finds patent on embryonic stem cell technology valid under reasonable terms while the position of the EPO is still open

Prüfer & Partner GbR
-
European Union, Germany
-
February 1 2013

Following the preliminary ruling of the Court of Justice of the European Union (CJEU; case C-3410), the long awaited final decision of the German

next >

Search results

Interim relief granted in challenge to EMA's decision to disclose pre-clinical and clinical information from an application for a centralised marketing authorisation

Dispelling the Myriad gene patent harmonization myth

IP challenges for the personalised medicines industry - gene claims (part 1)

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

EPO shies away from taking a stand on human embryonic stem cells

First court ruling on the EU nutrition and health claims regulation “health claim” given a very broad meaning

Dutch Supreme Court raises prejudicial questions to European Court of Justice regarding relief from import duties for certain pharmaceutical substances

Overview of patent-statutory subject matter in biotechnology

Ban on embryonic stem cell patenting in Europe Court of Justice rules on meaning of "human embryo" in stem cells debate

German Supreme Court finally finds patent on embryonic stem cell technology valid under reasonable terms while the position of the EPO is still open

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea